AOD-9604
Anti-Obesity Drug 9604 · hGH fragment 176-191
A modified fragment of human growth hormone studied for lipolytic activity without the growth-promoting effects of full hGH.
At a glance
- Category
- Metabolic
- Half-life
- ~30 minutes
- Typical vial sizes
- 2 mg · 5 mg
- Commonly cited dose
- 250–500 mcg
- Frequency
- once daily
- Routes
- Subcutaneous
A 2 mg vial, worked through.
Reconstituting a 2 mg vial of AOD-9604 with 2 mL of bacteriostatic water gives 1 mg/mL. A 250 mcg dose is then:
Storage
- Lyophilised (unmixed)
- Refrigerated.
- Reconstituted
- Refrigerate at 2–8°C.
What people log it against
Outcomes users commonly track alongside this compound. Listing them is not a claim that it produces them.
- Body composition tracking
References
The figures on this page have not yet been verified against primary literature. Treat them as provisional and confirm against a primary source before relying on them.
Run your own numbers
Pick AOD-9604 from the preset list to start from a typical vial.
As printed on the vial label
How much you inject into the vial
1000 mcg = 1 mg
Fills in a common vial size and the low end of commonly cited protocols. Always check against your own vial.
on a 1 mL U-100 insulin syringe
- Concentration
- 5 mg/mL
- Volume
- 0.05 mL
- Doses in this vial
- 40
VialPal does the arithmetic — it does not tell you what to take. Dose decisions belong between you and a qualified clinician.